Korro Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Korro Bio and other ETFs, options, and stocks.About KRRO
Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B.
CEORam Aiyar
CEORam Aiyar
Employees104
Employees104
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2018
Founded2018
Employees104
Employees104
KRRO Key Statistics
Market cap84.85M
Market cap84.85M
Price-Earnings ratio-0.95
Price-Earnings ratio-0.95
Dividend yield—
Dividend yield—
Average volume183.71K
Average volume183.71K
High today$9.05
High today$9.05
Low today$8.75
Low today$8.75
Open price$9.00
Open price$9.00
Volume35.37K
Volume35.37K
52 Week high$55.89
52 Week high$55.89
52 Week low$5.20
52 Week low$5.20
Stock Snapshot
The current Korro Bio(KRRO) stock price is $8.96, with a market capitalization of 84.85M. The stock trades at a price-to-earnings (P/E) ratio of -0.95.
During the trading session on 2026-01-14, Korro Bio(KRRO) shares reached a daily high of $9.05 and a low of $8.75. At a current price of $8.96, the stock is +2.4% higher than the low and still -1.0% under the high.
Trading activity shows a volume of 35.37K, compared to an average daily volume of 183.71K.
The stock's 52-week range extends from a low of $5.20 to a high of $55.89.
The stock's 52-week range extends from a low of $5.20 to a high of $55.89.
Analyst ratings
100%
of 10 ratingsBuy
0%
Hold
100%
Sell
0%
People also own
Based on the portfolios of people who own KRRO. This list is generated using Robinhood data, and it’s not a recommendation.